Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nang Kuang Pharmaceutical CoTPE:1752 -1.10%88 PS Ratio is 1.47 as of Jul. 15, 2026, which is 31% below its 10-year median of 2.12. GuruFocus rates TPE:1752 with a GF Score™ of 88/100 and a GF Value™ of NT$46.62 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 805 Medical Devices & Instruments companies, Nang Kuang Pharmaceutical Co ranks better than 70.19% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Nang Kuang Pharmaceutical Co's share price is NT$31.35.
Nang Kuang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 was NT$21.31. Hence, Nang Kuang Pharmaceutical Co's PS Ratio for today is 1.47.
Good Sign:
Nang Kuang Pharmaceutical Co Ltd stock PS Ratio (=1.49) is close to 5-year low of 1.49.
The historical rank and industry rank for Nang Kuang Pharmaceutical Co's PS Ratio or its related term are showing as below:
TPE:1752'
s PS Ratio Range Over the Past 10 Years
Min: 1.47 Med: 2.12 Max: 3.81
Current: 1.47
During the past 13 years, Nang Kuang Pharmaceutical Co's highest PS Ratio was 3.81. The lowest was 1.47. And the median was 2.12.
TPE:1752's PS Ratio is ranked better than 70.19% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 2.88
vs TPE:1752: 1.47
During the past 13 years, Nang Kuang Pharmaceutical Co's highest 3-Year average Revenue per Share Growth Rate was 9.00% per year. The lowest was -0.70% per year. And the median was 4.75% per year.
Back to Basics: PS Ratio
Nang Kuang Pharmaceutical Co (TPE:1752) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Nang Kuang Pharmaceutical Co PS Ratio Related Terms
Nang Kuang Pharmaceutical Co PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Nang Kuang Pharmaceutical Co's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nang Kuang Pharmaceutical Co PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nang Kuang Pharmaceutical Co's PS Ratio distribution charts can be found below:
* The bar in red indicates where Nang Kuang Pharmaceutical Co's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Nang Kuang Pharmaceutical Co's Share Price of today is NT$31.35. Nang Kuang Pharmaceutical Co's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$21.31.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Nang Kuang Pharmaceutical Co (TPE:1752) has a PS Ratio of 1.47 as of Jul. 15, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nang Kuang Pharmaceutical Co and its competitors. This is 31% below median its historical median of 2.12. Over the past decade, Nang Kuang Pharmaceutical Co's PS Ratio has ranged from 1.47 to 3.81. According to the industry distribution chart, Nang Kuang Pharmaceutical Co ranks #240 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 29.8%.
Is Nang Kuang Pharmaceutical Co's PS Ratio too high?
Nang Kuang Pharmaceutical Co's current PS Ratio of 1.47 is 31% below median its 10-year median of 2.12. Over the past 10 years, this metric has ranged from a low of 1.47 to a high of 3.81. The Medical Devices & Instruments industry median PS Ratio is 2.88. Nang Kuang Pharmaceutical Co's value of 1.47 is 49% below this industry median. Based on the distribution chart, Nang Kuang Pharmaceutical Co ranks #240 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nang Kuang Pharmaceutical Co has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nang Kuang Pharmaceutical Co's PS Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Nang Kuang Pharmaceutical Co ranks #240 out of 805 companies for PS Ratio. This puts Nang Kuang Pharmaceutical Co in the upper half of its industry. The industry median PS Ratio is 2.88. Nang Kuang Pharmaceutical Co's value of 1.47 is 49% below this benchmark. Historically, Nang Kuang Pharmaceutical Co's own PS Ratio has ranged from 1.47 to 3.81 over the past decade. While the company's 10-year median is 2.12 vs. the industry median of 2.88, Nang Kuang Pharmaceutical Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.88, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nang Kuang Pharmaceutical Co's current PS Ratio of 1.47 is 49% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Nang Kuang Pharmaceutical Co and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.88 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nang Kuang Pharmaceutical Co's current PS Ratio is 1.47, which is 31% below median its own 10-year median of 2.12. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nang Kuang Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co (TPE:1752) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$46.62, compared to a current price of NT$31.35 — trading 32.8% below its estimated fair value. The current PS Ratio is 1.47, which is 31% below median its 10-year median of 2.12 and 49% below the Medical Devices & Instruments industry median of 2.88. Nang Kuang Pharmaceutical Co's overall GF Score™ is 88/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Nang Kuang Pharmaceutical Co (TPE:1752), the current PS Ratio is 1.47 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nang Kuang Pharmaceutical Co (TPE:1752) Overvalued in 2026?
Based on GuruFocus' analysis, Nang Kuang Pharmaceutical Co stock appears to be undervalued.
The current stock price of NT$31.35 is trading 32.8% below its estimated GF Value™ of NT$46.62.
GuruFocus considers Nang Kuang Pharmaceutical Co to be Significantly Undervalued.
Key valuation signals for TPE:1752:
PS Ratio: 1.47 (31% below median its 10-year median of 2.12)
GF Value™: NT$46.62 vs. price of NT$31.35 (32.8% below fair value)
Industry Position: 49% below the Medical Devices & Instruments median (#240 of 805)
No single metric tells the full story. See the TPE:1752 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nang Kuang Pharmaceutical Co Ltd is a Taiwan-based company, its subsidiaries are engaged in the manufacture, processing, and trading, and import and export of pharmaceuticals and medical devices. Its products are Cardiovascular system medications, Gastrointestinal medications, Nervous system drugs, Nutrition and Metabolism, Hospital infusion solution, blood products, Anticancer immunomodulators, Musculoskeletal system, and Others. Geographically, the company operates in Taiwan, China, Japan, the USA, and Other countries.
88GF Score
Get the complete analysis for TPE:1752
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TPE:1752 has been successfully added to your 
